POINT Biopharma Global Inc. announced changes to its senior leadership team as well as its Board of Directors. Justyna Kelly, Vice President, Medical Isotope Development and Operations, has been promoted to Chief Operating Officer, effective December 1, 2021. With over 11 years of comprehensive experience in radiopharmaceuticals covering sterility assurance programs, building-out of GMP manufacturing facilities, and managing development programs, Ms. Kelly?s wide-range of experience uniquely qualifies her for this role. Todd Hockemeyer will continue in his role as EVP, US Manufacturing with expanded responsibilities to include isotope production. Jonathan Ross Goodman has been elected Lead Independent Director by the Board of Directors, effective November 22, 2021. Michael Gottlieb, Chief Commercial Officer, left the Company effective November 25, 2021, to pursue other opportunities.